EVEON celebrates its 10th anniversary and is ranked by Forbes as the 3rd most inventive French company in the medical technologies category.

EVEON will be at CPhI worldwide, on November 5-7, in Frankfurt (Germany). 

EVEON is proud to be in Forbes' ranking as one of the best French inventors, thanks to its strong portfolio of patents, to its development, to R&D investment.

Supported by the European Union, the project ISIS aims to develop and industrialize a connected and secure medical device for automated drug reconstitution.

EVEON was at 5 ° edition of the Lyophilization day, organized by A3P, on Thursday 4 July 2019, in Lyon (France). 

EVEON was at European partnering event MedFIT, on June 25-26 2019, in Lille (France). 

The presentation of the DIPSA project, needle-free piezoelectric injection device, to the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, received a favourable opinion in March 2019. The project was launched on Tuesday, April 15, 2019, at Cedrat Technologies (CTEC), project coordinator, with EVEON, as industrial partner, and the Grenoble Rheology and Processes Laboratory (LRP). 

EVEON, as part of a partnership with a pharmaceutical laboratory, has delivered, on schedule, the first functional prototypes based on the innovative medical device Intuity® Ject..

EVEON was at the 2^nd annual conference SMI Injectable Drug Delivery, on 15-16 May 2019, in London (UK). 

EVEON was in Lyon (France) for Medinov Connection, April 3-4  and Forum CLARA (cancer research), April 4-5.